Results 271 to 280 of about 572,501 (357)

NEAT1 is a therapeutic target for reversing T-cell exhaustion in bladder cancer. [PDF]

J Immunother Cancer
Li K, Niu L, Zhang X, Li T, Zhou X, Wang L, Han J, Wang Z.   +7 more
europepmc   +1 more source

Rodent monocyte‐derived macrophages do not express CD163: Comparative analysis using macrophages from living boreoeutherians

Developmental Dynamics, EarlyView.
Abstract Background CD163 is a scavenger receptor predominantly expressed on the surfaces of macrophages in various mammalian species and is a marker of anti‐inflammatory (M2‐like) macrophages. High density of CD163‐positive tumor‐associated macrophages (TAMs) is associated with worse prognosis in various patient tumors.
Yoichi Saito, Yukio Fujiwara, Yasuka L. Yamaguchi, Satomi S. Tanaka, Kyoko Miura, Yoshiyuki Hizukuri, Kyoko Yamashiro, Yasuhiro Hayashi, Yuta Nakashima, Yoshihiro Komohara   +9 more
wiley   +1 more source

Psychological Stress and Suicide in Bladder Cancer Patients

Bladder Cancer, 2018
Edward M. Messing
doaj   +1 more source

Lifetime water arsenic, genetic susceptibility, and bladder cancer in the New England Bladder Cancer Study. [PDF]

JNCI Cancer Spectr
Pomares-Millan H, Koutros S, Baris D, Schwenn M, Johnson A, Rothman N, Silverman DT, Leach SD, Karagas MR, Passarelli MN.   +9 more
europepmc   +1 more source

Fibroblast Growth Factor Receptor 3 Is a Rational Therapeutic Target in Bladder Cancer

, 2013
Kilian M. Gust, David J. McConkey, Shannon Awrey, Paul K. Hegarty, Jing Qing, Jolanta Bondaruk, Avi Ashkenazi, Bogdan Czerniak, Colin P. Dinney, Peter C. Black   +9 more
openalex   +1 more source

Calcitonin gene‐related peptide concentration in cerebrospinal fluid and serum in horses affected by trigeminal‐mediated headshaking

Equine Veterinary Journal, EarlyView.
Abstract Background Trigeminal‐mediated headshaking (TMHS) in horses shares clinical features with human trigeminal neuralgia (HTN). Increased levels of the neuropeptide calcitonin gene‐related peptide (CGRP) have been found in the blood and cerebrospinal fluid (CSF) of HTN patients. Inhibition of CGRP in humans has shown promise for pain relief.
Lisa Annabel Weber, Hilke Oltmanns, Ludovica Chiavaccini, Kirstie J. Pickles, Veronica Roberts, Tanja Kloock, Tobias Niebuhr, Karsten Feige   +7 more
wiley   +1 more source

Clinical Trials Corner

Bladder Cancer, 2016
Piyush K. Agarwal MD, Cora N. Sternberg MD, FACP   +1 more
doaj   +1 more source

Functional and Mechanistic Insights of 3-Hydroxybutyrate (3-OBA) in Bladder Cancer. [PDF]

Molecules
Silva A, Félix AM, Gonçalves CS, Longatto-Filho A, Baltazar F, Afonso J.   +5 more
europepmc   +1 more source

Loss of the Y Chromosome in Oral Potentially Premalignant Disorders Predicts Malignant Progression: An Integrative Cross‐Species Multi‐Cohort Bioinformatic Study

Head &Neck, EarlyView.
ABSTRACT Background The loss of the Y chromosome (LOY) and the extreme down‐regulation of Y chromosome gene expression (EDY) are frequently observed in oral squamous cell carcinoma (OSCC). However, their roles in oral potentially malignant disorders (OPMDs) are unclear.
Rui Han, Jos B. Poell, Cristina Conde‐Lopez, Tuula Salo, Ina Kurth, Ruud H. Brakenhoff, Jochen Hess   +6 more
wiley   +1 more source

Urinary Microbiota Composition in Treatment-Naïve Bladder Cancer: A Case-Control Study with Tumor Invasiveness Stratification. [PDF]

Medicina (Kaunas)
Kayer A, Özen A, Dinleyici EÇ.
europepmc   +1 more source